EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

The Mitochondrial DNA 4977-bp Deletion in Patients with Colorectal Cancer: a Case-control Study in Iran

Sharareh Kamfar, Fariba Alaei, Reza Zaferani, Vahide Zeinali

Iranian Journal of Blood and Cancer · 2022

DOI: 10.58209/ijbc.14.4.104 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Iranian Journal of Blood and Cancer, 2022. Verfasst von Sharareh Kamfar und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kamfar, S., Alaei, F., Zaferani, R., & Zeinali, V. (2022). The Mitochondrial DNA 4977-bp Deletion in Patients with Colorectal Cancer: a Case-control Study in Iran. Iranian Journal of Blood and Cancer. https://doi.org/10.58209/ijbc.14.4.104

Vancouver

Kamfar S, Alaei F, Zaferani R, Zeinali V. The Mitochondrial DNA 4977-bp Deletion in Patients with Colorectal Cancer: a Case-control Study in Iran. Iranian Journal of Blood and Cancer. 2022. doi:10.58209/ijbc.14.4.104

BibTeX
@article{Kamfar2022,
  author = {Kamfar, Sharareh and Alaei, Fariba and Zaferani, Reza and Zeinali, Vahide},
  title = {The Mitochondrial DNA 4977-bp Deletion in Patients with Colorectal Cancer: a Case-control Study in Iran},
  journal = {Iranian Journal of Blood and Cancer},
  year = {2022},
  doi = {10.58209/ijbc.14.4.104}
}
Kostenlos starten →